Agenus
AGEN
#8237
Rank
S$0.45 B
Marketcap
S$10.01
Share price
8.73%
Change (1 day)
71.37%
Change (1 year)

Earnings for Agenus (AGEN)

Earnings in 2026 (TTM): S$0.15 Billion

According to Agenus 's latest financial reports the company's current earnings are S$0.12 Billion. In 2025 the company made an earning of S$66.57 Million, an increase over its 2024 earnings that were of -S$0.15 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Agenus from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) S$0.15 B131.81%
2025 S$66.57 M-145.52%
2024 -S$0.15 Billion-28.13%
2023 -S$0.21 Billion-5.5%
2022 -S$0.22 Billion-556.26%
2021 S$47.19 M-130.37%
2020 -S$0.16 Billion73.75%
2019 -S$89.44 Million-48.74%
2018 -S$0.18 Billion34.32%
2017 -S$0.13 Billion-7.16%
2016 -S$0.14 Billion26.55%
2015 -S$0.12 Billion110.24%
2014 -S$52.6 Million49.12%
2013 -S$35.27 Million
2011 -S$24.35 Million-12.25%
2010 -S$27.75 Million-21.41%
2009 -S$35.31 Million-26.86%
2008 -S$48.28 Million13.72%
2007 -S$42.46 Million-33.4%
2006 -S$63.75 Million-31.84%
2005 -S$93.52 Million9.74%
2004 -S$85.22 Million-0.8%
2003 -S$85.91 Million17.37%
2002 -S$73.2 Million37.83%
2001 -S$53.11 Million55.99%
2000 -S$34.05 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$33.14 B 21,614.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$16.77 B 10,892.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$12.24 B 7,921.56%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$12.77 B 8,267.94%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
-S$0.4 Billion-358.33%๐Ÿ‡บ๐Ÿ‡ธ USA